Previous Close | 127.51 |
Open | 128.37 |
Bid | 50.91 x 1300 |
Ask | 203.63 x 800 |
Day's Range | 126.74 - 128.85 |
52 Week Range | 110.15 - 174.29 |
Volume | |
Avg. Volume | 121,379 |
Market Cap | 4.104B |
Beta (5Y Monthly) | 0.59 |
PE Ratio (TTM) | 38.25 |
EPS (TTM) | 3.34 |
Earnings Date | Oct 27, 2022 - Oct 31, 2022 |
Forward Dividend & Yield | 0.64 (0.50%) |
Ex-Dividend Date | Dec 27, 2021 |
1y Target Est | 160.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for BCPC
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending June 30, 2022. My name is Martin Bengtsson, chief financial officer; and hosting this call with me is Ted Harris, our chairman, CEO, and president. Following the advice of our counsel, auditors, and the SEC, at this time, I would like to read our forward-looking statement.
NEW HAMPTON, N.Y., July 29, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today second quarter net earnings of $29.8 million for 2022, compared to net earnings of $22.7 million for the second quarter 2021, adjusted net earnings(a) of $34.4 million, compared to $30.4 million in the prior year quarter, and adjusted EBITDA(a) of $56.5 million, compared to $50.1 million in the prior year quarter. Second Quarter 2022 Financial Highlights: Record net sales were $236.7 million, a